32G

(3aS,4S,6aR)-4-(5-{1-[4-(6-amino-9H-purin-9-yl)butyl]-1H-1,2,3-triazol-4-yl}pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one

Created:	2012-01-19
Last modified:	2012-12-21

Find Related PDB Entry
1 entries where 32G is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	63
Chiral Atom Count	3
Bond Count	67
Aromatic Bond Count	15

2D diagram of 32G

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3aS,4S,6aR)-4-(5-{1-[4-(6-amino-9H-purin-9-yl)butyl]-1H-1,2,3-triazol-4-yl}pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one
Systematic Name (OpenEye OEToolkits)	(3aS,4S,6aR)-4-[5-[1-[4-(6-aminopurin-9-yl)butyl]-1,2,3-triazol-4-yl]pentyl]-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one
Formula	C₂₁ H₃₀ N₁₀ O S
Molecular Weight	470.594
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C1NC2C(SCC2N1)CCCCCc3nnn(c3)CCCCn4c5ncnc(N)c5nc4
SMILES	CACTVS	3.370	Nc1ncnc2n(CCCCn3cc(CCCCC[CH]4SC[CH]5NC(=O)N[CH]45)nn3)cnc12
SMILES	OpenEye OEToolkits	1.7.6	c1c(nnn1CCCCn2cnc3c2ncnc3N)CCCCCC4C5C(CS4)NC(=O)N5
Canonical SMILES	CACTVS	3.370	Nc1ncnc2n(CCCCn3cc(CCCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)nn3)cnc12
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1c(nnn1CCCCn2cnc3c2ncnc3N)CCCCC[C@H]4[C@@H]5[C@H](CS4)NC(=O)N5
InChI	InChI	1.03	InChI=1S/C21H30N10OS/c22-19-18-20(24-12-23-19)30(13-25-18)8-4-5-9-31-10-14(28-29-31)6-2-1-3-7-16-17-15(11-33-16)26-21(32)27-17/h10,12-13,15-17H,1-9,11H2,(H2,22,23,24)(H2,26,27,32)/t15-,16-,17-/m0/s1
InChIKey	InChI	1.03	GCOZLSRXMOWRSO-ULQDDVLXSA-N

Related Resource References

Resource Name	Reference
PubChem	70679452
ChEMBL	CHEMBL3701289

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.